Bionomics Stock Price, News & Analysis
Company Description
Bionomics (NASDAQ: BNOX) is a publicly traded research and development in biotechnology company in the Pharmaceutical Preparations sector. The company has a market capitalization of $4.9M, ranking #6,720 among all listed U.S. companies by market cap.
BNOX stock has declined 80.4% over the past year. Shares last traded at $0.2531.
This page provides a comprehensive overview of BNOX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Bionomics (BNOX) stock last traded at $0.2531. Over the past 12 months, the stock has lost 80.4%. At a market capitalization of $4.9M, BNOX is classified as a micro-cap stock with approximately 19.5M shares outstanding.
Latest News
Bionomics has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include clinical trial, conferences. View all BNOX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
BNOX Company Profile & Sector Positioning
Bionomics (BNOX) operates in the Research and Development in Biotechnology industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.